DXF flagged for NYSE American noncompliance on equity and losses
Rhea-AI Filing Summary
Eason Technology Limited reported it received a NYSE American notice of noncompliance with continued listing standards. The exchange cited stockholders’ equity of RMB 28 million (approximately USD$3.8 million) as of December 31, 2024, and losses from continuing operations and/or net losses in three of the four most recent fiscal years.
The company must submit a compliance plan by November 13, 2025, and regain compliance by April 14, 2027, under Section 1009 procedures. If a plan is not submitted or accepted, or if progress and compliance are not achieved by the deadline, delisting proceedings may commence, with appeal rights under Section 1010 and Part 12. The notice has no immediate impact on the listing of the company’s ADSs, which will continue to trade during the cure period subject to other NYSE American requirements.
Positive
- None.
Negative
- NYSE American deficiency notice citing stockholders’ equity of RMB 28 million (about USD$3.8 million) and multi-year losses, with potential delisting if compliance plan and milestones are not met.
Insights
Listing deficiency raises delisting risk if plan fails.
The exchange flagged Eason Technology for low stockholders’ equity and multi-year losses, triggering Section 1009 procedures. The disclosed equity level is
Under these rules, the company must submit a plan by
ADSs remain listed during the cure period, contingent on meeting other NYSE American requirements. Actual outcome will depend on plan acceptance and the company’s ability to meet the compliance milestones outlined by the exchange.